Omthera Pharmaceuticals has a total of 113 patents globally, out of which 50 have been granted. Of these 113 patents, more than 30% patents are active. The United States of America is where Omthera Pharmaceuticals has filed the maximum number of patents, followed by Hong Kong (S.A.R.) and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Omthera Pharmaceuticals.
Omthera Pharmaceuticals was founded in 2008. Omthera Pharmaceuticals develops drugs to treat lipid disorders, specifically dyslipidemia, which involves high triglycerides and a higher risk of cardiovascular disease. Their drugs help healthcare providers improve patient health.
Do read about some of the most popular patents of Omthera Pharmaceuticals which have been covered by us in this article and also you can find Omthera Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Omthera Pharmaceuticals patent portfolio.
How many patents does Omthera Pharmaceuticals have?
Omthera Pharmaceuticals has a total of 113 patents globally. These patents belong to 12 unique patent families. Out of 113 patents, 35 patents are active.
How Many Patents did Omthera Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Omthera Pharmaceuticals Applications Filed | Omthera Pharmaceuticals Patents Granted |
2020 | – | 8 |
2019 | 4 | 11 |
2018 | 4 | 19 |
2017 | 5 | 4 |
2016 | 15 | 4 |
2015 | 9 | 3 |
2014 | 10 | 1 |
2013 | 56 | – |
2012 | 10 | – |
How many Omthera Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Omthera Pharmaceuticals File in Different Countries?
Countries in which Omthera Pharmaceuticals Filed Patents
Country | Patent |
United States of America | 12 |
Hong Kong (S.A.R.) | 9 |
China | 7 |
Japan | 7 |
Europe (EPO) | 6 |
Korea (South) | 5 |
Israel | 4 |
Australia | 3 |
New Zealand | 3 |
Mexico | 2 |
Canada | 2 |
Philippines | 2 |
India | 2 |
Singapore | 2 |
South Africa | 2 |
Malaysia | 2 |
Chile | 2 |
Brazil | 1 |
Estonia | 1 |
Portugal | 1 |
Germany | 1 |
Spain | 1 |
Austria | 1 |
Ecuador | 1 |
Hungary | 1 |
Saudi Arabia | 1 |
Costa Rica | 1 |
Slovenia | 1 |
Indonesia | 1 |
Thailand | 1 |
Croatia | 1 |
Peru | 1 |
Argentina | 1 |
Poland | 1 |
Kazakhstan | 1 |
Russian Federation | 1 |
Brunei | 1 |
Serbia | 1 |
Viet Nam | 1 |
Slovakia | 1 |
Cyprus | 1 |
Eurasian Patent Organization | 1 |
Malta | 1 |
Taiwan | 1 |
Denmark | 1 |
Ukraine | 1 |
Dominican Republic | 1 |
Colombia | 1 |
Norway | 1 |
Lithuania | 1 |
Where are Research Centers of Omthera Pharmaceuticals Patents Located?
10 Best Omthera Pharmaceuticals Patents
US20130095179A1 is the most popular patent in the Omthera Pharmaceuticals portfolio. It has received 116 citations so far from companies like Amarin Pharmaceuticals Ireland Limited, Matinas Biopharma, Evonik Technochemie.
Below is the list of 10 most cited patents of Omthera Pharmaceuticals:
Publication Number | Citation Count |
US20130095179A1 | 116 |
US20130295173A1 | 115 |
WO2013103902A1 | 32 |
WO2013169797A1 | 21 |
US9050308B2 | 14 |
WO2013040507A1 | 11 |
US9050309B2 | 8 |
WO2016130417A1 | 7 |
WO2013059669A1 | 6 |
CN103957903A | 4 |
What are Omthera Pharmaceuticals key innovation segments?
What Technologies are Covered by Omthera Pharmaceuticals?
The chart below distributes patents filed by Omthera Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Omthera Pharmaceuticals thinks it’s important to protect particular technology inventions.
R&D Focus: How has Omthera Pharmaceuticals search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!